| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ff8b1bdd6e43354fa4785c27096e790 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 |
| filingDate |
2002-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6171e8626e3417e6eef7113a9d6cada4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c60a07d5b354bd8567487352f827afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b934b967b861206533f3bdaa517261bf |
| publicationDate |
2002-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-517053-A |
| titleOfInvention |
Microgranules or micro-tablets having 20-2000 micrometers containing Li salts (carbonate, acetate, glutamate, thionate or sulphate) |
| abstract |
Multiparticulate formulation in the form of microgranules or micro-tablets having dimensions ranging from 200 to 2000 microns, containing Lithium salts, where the microgranules or micro-tablets have a modified release or partly modified and partly conventional release. This formulation has a Lithium salts content of at least 500 mg/g and an in vitro dissolution profile that that make it suitable for once a day administration. Multiparticulate formulation in the form of microgranules or micro-tablets having dimensions ranging from 200 to 2000 micrometers, containing Lithium salts are prepared by involving the steps: (i) Granulation of a Lithium salt in powder with a solution of a binder such as polyvinylpyrrolidone, polyethyleneglycol, saccharose or gelatin; (ii) Sieving the granules in the range 200 to 2000 microns to make a conventional release formulation; (iii) Coating all or part of the sieved granules to make a modified release formulation. |
| priorityDate |
2001-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |